ArticleNutrition & diabetes2025
The role of circadian rest-activity rhythm for the link between 25-hydroxyvitamin D and type 2 diabetes: a cohort study.
Article in Nutrition & diabetes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTemporal distribution and amplitude of physical activity/inactivity in 24 h known as circadian rest-activity rhythm may predict the risk of various metabolic diseases, including type 2 diabetes (T2D), yet the mechanisms behind the diurnal behavior patterns remain largely unexplored.
methodsThis study included 74,165 UK Biobank participants who were free of T2D at baseline. Circadian rest-activity rhythm (CRAR) characteristics, including amplitude (strength), acrophase (timing of peak activity), pseudo-F (robustness), and mesor (height), were assessed using an extended cosine model applied to accelerometer data. T2D was assessed using the established UK Biobank algorithms. Using Cox regression and restricted cubic spline models, we examined the association between CRAR and incident T2D as well as subsequent all-cause mortality among individuals developed T2D during the follow-up. Mediation analysis explored the mediating effects of blood and metabolic biomarkers.
resultsDuring a median follow-up of 7.9 years, 1784 T2D cases were documented. We found that CRAR abnormalities was associated with a higher risk of incident T2D compared to optimal CRAR, and the multivariate adjusted hazard ratios (HRs) (95% CI) were 1.48 (1.31, 1.67) for low amplitude, 1.25 (1.07, 1.45) for delayed acrophase, 1.17 (1.04, 1.31) for pseudo-F, and 1.55 (1.38, 1.74) for low mesor. Furthermore, low amplitude and low mesor were associated with higher all-cause mortality following the diagnosis of T2D. Serum vitamin D emerged as a crucial mediator in the association between CRAR abnormalities and the risk of T2D as well as subsequent all-cause mortality.
conclusionOur study suggests that CRAR abnormalities are linked to an elevated risk of incident T2D and subsequent mortality. These associations are mediated by blood and metabolic biomarkers, with serum vitamin D playing a significant role as the primary mediator.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.